Analyze Diet
Frontiers in veterinary science2024; 11; 1389798; doi: 10.3389/fvets.2024.1389798

Determinants of joint effusion in tarsocrural osteochondrosis of yearling Standardbred horses.

Abstract: Tarsocrural osteochondrosis (OCD) is a developmental orthopedic disease commonly affecting young Standardbreds, with different fragment localization and size. Clinically, it is characterized by variable synovial effusion in the absence of lameness, whose determinants are ill-defined. We hypothesized that localization and physical characteristics of the osteochondral fragments like dimensions, multifragmentation, and instability influence joint effusion and correlate with synovial markers of cartilage degradation and inflammation. Clinical data, synovial fluid and intact osteochondral fragments were collected from 79 Standardbred horses, aged between 12 and 18 months, operated for tarsocrural OCD. The severity of tarsocrural joint effusion was assessed semi-quantitatively. The osteochondral fragment site was defined radiographically at the distal intermediate ridge of the tibia (DIRT), medial malleolus (MM) of the tibia, and/or lateral trochlear ridge (LTR) of the talus. Size, stability, and arthroscopic appearance (unique or multi-fragmented aspect) of the fragments were determined intra-operatively. Synovial concentrations of C-terminal cross-linked telopeptides of type II collagen (CTX-II), leukotriene B4 (LTB4), and prostaglandin E2 (PGE2) were quantified. Tarsocrural synovial effusion was significantly affected by localization and stability of the fragments, with MM-located and unstable fragments being associated with highest joint effusion. Concentrations of CTX-II, LTB4, and PGE2 positively correlated with the severity of synovial effusion. This study underlines characteristics of the osteochondral fragments determining higher synovial effusion in OCD-affected tarsocrural joints and suggests both inflammation and extra-cellular matrix degradation are active processes in OCD pathology.
Publication Date: 2024-07-24 PubMed ID: 39113724PubMed Central: PMC11303144DOI: 10.3389/fvets.2024.1389798Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the factors that contribute to joint effusion, a symptom often seen in young Standardbred horses suffering from tarsocrural osteochondrosis (OCD), a developmental orthopedic disease. The researchers hypothesize that the physical characteristics of fragments, including their size and location, impact joint effusion. The study uses data from 79 horses, exploring the correlation between these factors and synovial markers linked to cartilage degradation and inflammation.

Understanding Tarsocrural Osteochondrosis (OCD)

  • Tarsocrural OCD is a developmental orthopedic condition that typically affects Standardbred horses when they are between 12 and 18 months old.
  • This disease features osteochondral fragments of varying sizes and localizations, and a key clinical characteristic is fluctuating synovial effusion – the accumulation of fluid in a joint – despite no presence of lameness in the affected horses.

Research Purpose and hypothesis

  • The aim of the study was to evaluate what factors directly contribute to synovial effusion in OCD-affected young horses.
  • The researchers hypothesized that the location and physical features of the osteochondral fragments – like their dimensions, whether or not they were fragmented, and their degree of stability – would have an influence over joint effusion and correlate with synovial markers of cartilage degradation and inflammation.

Study Methodology and Key Findings

  • The study involved the collection of clinical data, synovial fluid, and osteochondral fragments from 79 Standardbred horses operated for tarsocrural OCD.
  • The severity of tarsocrural joint effusion was assessed semi-quantitatively, and the osteochondral fragment site was determined radiographically.
  • The osteochondral fragments were evaluated for size, stability, and arthroscopic appearance during the operation.
  • Synovial concentrations of C-terminal cross-linked telopeptides of type II collagen (CTX-II), leukotriene B4 (LTB4), and prostaglandin E2 (PGE2) – markers associated with cartilage degradation and inflammation – were quantified.
  • The study found that tarsocrural synovial effusion was significantly impacted by the location and stability of the fragments. Fragments located at the medial malleolus (MM) of the tibia and unstable fragments were associated with the highest joint effusion.
  • There was a positive correlation between the concentrations of CTX-II, LTB4, and PGE2 and the severity of synovial effusion.

Conclusion

  • This study provides valuable insights into the factors that influence synovial effusion in horses with OCD, particularly the role of fragment location and stability.
  • The findings of the research suggest that both inflammation and degradation of the extracellular matrix are active processes in the pathology of OCD.

Cite This Article

APA
Bertuglia A, Pallante M, Pagliara E, Valle D, Bergamini L, Bollo E, Bullone M, Riccio B. (2024). Determinants of joint effusion in tarsocrural osteochondrosis of yearling Standardbred horses. Front Vet Sci, 11, 1389798. https://doi.org/10.3389/fvets.2024.1389798

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 11
Pages: 1389798

Researcher Affiliations

Bertuglia, Andrea
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.
Pallante, Marcello
  • Dipartimento di Scienze Medico-Veterinarie, Università di Parma, Parma, Italy.
Pagliara, Eleonora
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.
Valle, Daniela
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.
Bergamini, Lara
  • Allevamento Le Fontanette, Vigone, Italy.
Bollo, Enrico
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.
Bullone, Michela
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.
Riccio, Barbara
  • Dipartimento di Scienze Veterinarie, Università di Torino, Turin, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 42 references
  1. Dik KJ, Enzerink E, van Weeren PR. Radiographic development of osteochondral abnormalities, in the hock and stifle of Dutch warmblood foals, from age 1 to 11 months.. Equine Vet J Suppl (1999) 31:9–15.
  2. Olstad K, Cnudde V, Masschaele B, Thomassen R, Dolvik NI. Micro-computed tomography of early lesions of osteochondrosis in the tarsus of foals.. Bone (2008) 43:574–83.
    doi: 10.1016/j.bone.2008.04.024pubmed: 18579463google scholar: lookup
  3. Ytrehus B, Carlson CS, Ekman S. Etiology and pathogenesis of osteochondrosis.. Vet Pathol (2007) 44:429–48.
    doi: 10.1354/vp.44-4-429pubmed: 17606505google scholar: lookup
  4. Laverty S, Girard C. Pathogenesis of epiphyseal osteochondrosis.. Vet J (2013) 197:3–12.
    doi: 10.1016/j.tvjl.2013.03.035pubmed: 23647656google scholar: lookup
  5. Pool RR. Difficulties in definition of equine osteochondrosis; differentiation of developmental and acquired lesions.. Equine Vet J (1993) 25:5–12.
  6. Lykkjen S, Roed KH, Dolvik NI. Osteochondrosis and osteochondral fragments in Standardbred trotters: prevalence and relationships.. Equine Vet J (2012) 44:332–8.
  7. Grøndahl AM, Dolvik NI. Heritability estimations of osteochondrosis in the tibiotarsal joint and of bony fragments in the palmar/plantar portion of the metacarpo- and metatarsophalangeal joints of horses.. J Am Vet Med Assoc (1993) 203:101–4.
    doi: 10.2460/javma.1993.203.01.101pubmed: 8407439google scholar: lookup
  8. McIlwraith CW, Foerner J, Davis DM. Osteochondritis dissecans of the tarsocrural joint: results of treatment with arthroscopic surgery.. Equine Vet J (1991) 23:155–62.
  9. Jacquet S, Robert C, Valette J-P, Denoix JM. Evolution of radiographic findings detected in the limbs of 321 young horses between the ages of 6 and 18 months.. Vet J (2013) 197:58–64.
    doi: 10.1016/j.tvjl.2013.03.042pubmed: 23660154google scholar: lookup
  10. Brink P, Skydsgaard M, Teige J, Tverdal A, Dolvik NI. Association between clinical signs and histopathologic changes in the synovium of the tarsocrural joint of horses with osteochondritis dissecans of the tibia.. Am J Vet Res (2010) 71:47–54.
    doi: 10.2460/ajvr.71.1.47pubmed: 20043780google scholar: lookup
  11. Boorman S, Hofmeister EH, Ross MW, Ralston S, Bell G, Mackie S. Influence of osteochondrosis on the longevity and racing performance of Standardbred trotters and pacers.. Vet Surg (2021) 50:507–16.
    doi: 10.1111/vsu.13568pubmed: 33460472google scholar: lookup
  12. McCoy AM, Ralston SL, McCue ME. Short- and long-term racing performance of Standardbred pacers and trotters after early surgical intervention for tarsal osteochondrosis.. Equine Vet J (2015) 47:438–44.
    doi: 10.1111/evj.12297pmc: PMC4229490pubmed: 24819047google scholar: lookup
  13. De Grauw JC, Brama PA, Wiemer P, Brommer H, van de Lest CH, van Weeren PR. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.. Am J Vet Res (2006) 67:1156–62.
    doi: 10.2460/ajvr.67.7.1156pubmed: 16817736google scholar: lookup
  14. Machado TSL, Correia da Silva LCL, Baccarin RYA, Michelacci YM. Synovial fluid chondroitin sulphate indicates abnormal joint metabolism in asymptomatic osteochondritic horses.. Equine Vet J (2012) 44:404–11.
  15. Verwilghen DR, Martens A, Busschers E, Franck T, Deberg M, Henrotin Y. Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis.. Vet Res Commun (2011) 35:401–8.
    doi: 10.1007/s11259-011-9487-5pubmed: 21681550google scholar: lookup
  16. Brink P, Smith RKW, Tverdal A, Dolvik NI. Changes in synovial fluid biomarker concentrations following arthroscopic surgery in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.. Am J Vet Res (2015) 76:599–607.
    doi: 10.2460/ajvr.76.7.599pubmed: 26111089google scholar: lookup
  17. Lambert C, Borderie D, Dubuc JE, Rannou F, Henrotin Y. Type II collagen peptide Coll2-1 is an actor of synovitis.. Osteoarthr Cartil (2019) 27:1680–91.
    doi: 10.1016/j.joca.2019.07.009pubmed: 31325494google scholar: lookup
  18. Bergin BJ, Pierce SW, Bramlage LR, Stromberg A. Oral hyaluronan gel reduces post operative tarsocrural effusion in the yearling thoroughbred.. Equine Vet J (2010) 38:375–8.
    doi: 10.2746/042516406777749218pubmed: 16866209google scholar: lookup
  19. Smallwood JE, Shively MJ, Rendano VT, Habel RE. A standardized nomenclature for radiographic projections used in veterinary medicine.. Vet Radiol (1985) 26:2–9.
  20. MclIwraith CW, Nixon A, Wright I. Diagnostic and surgical arthroscopy in the horse, 4th.. (2015). St.Louis, Missouri: Mosby Ltd. 244–257.
  21. Merchán A, Koenig J, Côté N, Cribb N, Monteith G. Fragment size is associated with post-operative complications following elective arthroscopy of the tibiotarsal joint of horses.. Can Vet J (2022) 63:74–80.
    pmc: PMC8682936pubmed: 34975171
  22. Guhl JF. Arthroscopic treatment of osteochondritis dissecans: preliminary report.. Orthop Clin North Am (1979) 10:671–84.
    doi: 10.1016/S0030-5898(20)30759-8pubmed: 460840google scholar: lookup
  23. Gangl M, Serteyn D, Lejeun JP, Schneider N, Grulke S, Peters F. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions.. Res Vet Sci (2007) 82:68–75.
    doi: 10.1016/j.rvsc.2006.03.008pubmed: 16780906google scholar: lookup
  24. Trumble TN, Brown MP, Merritt KA, Billinghurst RC. CTX II (Cartilaps) assay using equine synovial fluid.. Osteoarthr Cartil (2006) 14:70–1.
  25. Cleary OB, Trumble TN, Merritt KA, Brown MP. Effect of exercise and osteochondral injury on synovial fluid and serum concentrations of carboxy-terminal telopeptide fragments of type II collagen in racehorses.. Am J Vet Res (2010) 71:33–40.
    doi: 10.2460/ajvr.71.1.33pubmed: 20043778google scholar: lookup
  26. Gibson KT, Hodge H, Whittem T. Inflammatory mediators in equine synovial fluid.. Aust Vet J (1996) 73:148–51.
  27. Yonetani Y, Nakamura N, Natsuume T, Shiozaki Y, Tanaka Y, Horibe S. Histological evaluation of juvenile osteochondritis dissecans of the knee: a case series.. Knee Surg Sports Traumatolog Arthrosc (2010) 18:723–30.
    doi: 10.1007/s00167-009-0898-6pubmed: 19760400google scholar: lookup
  28. Olstad K, Hendrickson EHS, Carlson CS, Ekman S, Dolvik N. Transection of vessels in epiphyseal cartilage canals leads to osteochondrosis and osteochondrosis dissecans in the femoro-patellar joint of foals; a potential model of juvenile osteochondritis dissecans.. Osteoarthr Cartil (2013) 21:730–8.
    doi: 10.1016/j.joca.2013.02.005pubmed: 23428601google scholar: lookup
  29. Martel G, Kiss S, Gilbert G, Anne-Archard N, Richard H, Moser T. Differences in the vascular tree of the femoral trochlear growth cartilage at osteochondrosis-susceptible sites in foals revealed by SWI 3T MRI.. J Orthop Res (2016) 34:1539–46.
    doi: 10.1002/jor.23149pubmed: 26740060google scholar: lookup
  30. Zbojniewicz A, Stringer KF, Laor T, Wall EJ. Juvenile osteochondrosis dissecans: correlation between histopathology and MRI.. Am J Roentgenol (2015) 205:W114–23.
    doi: 10.2214/AJR.14.13579pubmed: 26102409google scholar: lookup
  31. Brittberg M. Knee osteochondritis dissecans-treatment technical aspects.. J Orthop (2022) 34:104–10.
    doi: 10.1016/j.jor.2022.08.005pmc: PMC9428728pubmed: 36060730google scholar: lookup
  32. Uozumi H, Sugita T, Aizawa T, Takahashi A, Ohnuma M, Itoi E. Histologic findings and possible causes of osteochondritis dissecans of the knee.. Am J Sports Med (2009) 37:2003–8.
    doi: 10.1177/0363546509346542pubmed: 19737988google scholar: lookup
  33. Laverty S, Ionescu M, Marcoux M, Bouré L, Doizé B, Poole AR. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochodrosis.. J Orthop Res (2000) 18:399–405.
    doi: 10.1002/jor.1100180311pubmed: 10937626google scholar: lookup
  34. Laverty S, Okouneff S, Ionescu MJ, Reiner A, Pidoux I, Webber C. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis.. J Orthop Res (2002) 20:1282–9.
    doi: 10.1016/S0736-0266(02)00053-0pubmed: 12472241google scholar: lookup
  35. May SA, Hooke RE, Lees P. Bone fragments stimulate equine synovial lining cells to produce the inflammatory mediator prostaglandin E2.. Equine Vet J Suppl (1988) 20:131–2.
  36. Lambert C, Zappia J, Sanchez C, Florin A, Dubuc JE, Henrotin Y. The damage-associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature.. Front Med (2021) 7:607186.
    doi: 10.3389/fmed.2020.607186pmc: PMC7847938pubmed: 33537330google scholar: lookup
  37. Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, Delaissé JM, Percival MD, Garnero P. The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.. Osteoarthr Cartil (2008) 16:1183–91.
    doi: 10.1016/j.joca.2008.02.008pubmed: 18403221google scholar: lookup
  38. Nicholson AM, Trumble TN, Merritt KA, Brown MP. Associations of horse age, joint type, and osteochondral injury with serum and synovial fluid concentrations of type II collagen biomarkers in thoroughbreds.. Am J Vet Res (2010) 71:741–9.
    doi: 10.2460/ajvr.71.7.741pubmed: 20594075google scholar: lookup
  39. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.. Arthritis Rheum (2002) 46:2613–24.
    doi: 10.1002/art.10576pubmed: 12384919google scholar: lookup
  40. Bertuglia A, Pagliara E, Grego E, Ricci A, Brkljaca-Bottegaro N. Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.. BMC Vet Res (2016) 12:246.
    doi: 10.1186/s12917-016-0873-7pmc: PMC5100096pubmed: 27821120google scholar: lookup
  41. Duclos ME, Roualdes O, Cararo R. Significance of the serum CTX-II level in an osteoarthritis animal model: a 5-months longitudinal study.. Osteoarthr Cartil (2010) 18:1467–76.
    doi: 10.1016/j.joca.2010.07.007pubmed: 21056352google scholar: lookup
  42. Van Spil WE, Bijlsma JW, Mastbergen SC, Lafeber FP. Association of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from check, a cohort study of early osteoarthritis.. Osteoarthr Cartil (2012) 20:S78–S296.
    doi: 10.1016/j.joca.2012.02.066pubmed: 22689318google scholar: lookup